Literature DB >> 29496039

Characterization of epithelial oral dysplasia in non-smokers: First steps towards precision medicine.

L D Rock1, M P Rosin2, L Zhang3, B Chan4, B Shariati5, D M Laronde4.   

Abstract

OBJECTIVES: Tobacco usage is the strongest risk factor in the development of oral squamous cell carcinoma (OSCC), which mandates careful screening for oral cancers in smokers. However, there are indications that oral potentially malignant lesions, such as oral epithelial dysplasia (OED), in non-smokers (NS) have a higher cancer risk than those in smokers. Without tobacco as an etiology, the development of these lesions in NS may suggest genetic susceptibility. The increasing incidence of OSCC in NS calls for a better understanding of the natural history of OED in NS as compared to that of smokers.
MATERIALS AND METHODS: Patients from a population-based longitudinal study with more than 10 years of follow up were analyzed. Of the 455 patients with primary OED (233 mild and 212 moderate dysplasia), 139 were NS and 306 were smokers. Demographic and habit information, clinical information (lesion site, size and appearance; toluidine blue and fluorescent visualization), microsatellite analysis for loss of heterozygosity (LOH) and outcome (progression) were compared between the two groups. RESULTS AND
CONCLUSIONS: The majority of patients with OED were smokers. Of these, more were males, non-Caucasians and heavy drinkers. A significantly higher number of OED in NS were in the tongue, whereas a significantly higher number of OED in smokers were in the floor of mouth (FOM). OED in NS showed a greater than 2-fold increase in cancer progression. Strikingly, OED located in the FOM in NS showed a 38-fold increase in cancer progression as compared to those in smokers.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomarkers; Cancer progression; Neoplasm, epithelial; Non-smokers; Oral cancer; Oral leukoplakia; Oral premalignant lesions; Pathology, oral; Precancerous conditions; Predictive markers

Mesh:

Year:  2018        PMID: 29496039      PMCID: PMC5836799          DOI: 10.1016/j.oraloncology.2018.01.028

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  48 in total

1.  Molecular markers of the risk of oral cancer.

Authors:  S M Lippman; W K Hong
Journal:  N Engl J Med       Date:  2001-04-26       Impact factor: 91.245

Review 2.  Living with oral cancer: epidemiology with particular reference to prevalence and life-style changes that influence survival.

Authors:  Saman Warnakulasuriya
Journal:  Oral Oncol       Date:  2010-04-18       Impact factor: 5.337

3.  Personalized medicine in the era of genomics.

Authors:  Wylie Burke; Bruce M Psaty
Journal:  JAMA       Date:  2007-10-10       Impact factor: 56.272

Review 4.  Risk factors for squamous cell carcinoma of the oral cavity in young people--a comprehensive literature review.

Authors:  C D Llewellyn; N W Johnson; K A Warnakulasuriya
Journal:  Oral Oncol       Date:  2001-07       Impact factor: 5.337

Review 5.  Oral premalignant lesions: from a clinical perspective.

Authors:  Teruo Amagasa; Masashi Yamashiro; Narikazu Uzawa
Journal:  Int J Clin Oncol       Date:  2011-01-12       Impact factor: 3.402

6.  Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions.

Authors:  Cristian Tomasetti; Bert Vogelstein
Journal:  Science       Date:  2015-01-02       Impact factor: 47.728

Review 7.  Oral cancer prevention and the evolution of molecular-targeted drug development.

Authors:  Scott M Lippman; Jon Sudbø; Waun Ki Hong
Journal:  J Clin Oncol       Date:  2005-01-10       Impact factor: 44.544

Review 8.  Oral cancer risk and molecular markers.

Authors:  Eduardo Chimenos-Küstner; Imma Font-Costa; José López-López
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2004 Nov-Dec

9.  Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers.

Authors:  Curtis R Pickering; Jiexin Zhang; David M Neskey; Mei Zhao; Samar A Jasser; Jiping Wang; Alexandra Ward; C Jillian Tsai; Marcus V Ortega Alves; Jane H Zhou; Jennifer Drummond; Adel K El-Naggar; Richard Gibbs; John N Weinstein; David A Wheeler; Jing Wang; Mitchell J Frederick; Jeffrey N Myers
Journal:  Clin Cancer Res       Date:  2014-05-29       Impact factor: 12.531

10.  Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis.

Authors:  V Bagnardi; M Rota; E Botteri; I Tramacere; F Islami; V Fedirko; L Scotti; M Jenab; F Turati; E Pasquali; C Pelucchi; C Galeone; R Bellocco; E Negri; G Corrao; P Boffetta; C La Vecchia
Journal:  Br J Cancer       Date:  2014-11-25       Impact factor: 7.640

View more
  8 in total

1.  Autofluorescence Imaging to Monitor the Progression of Oral Potentially Malignant Disorders.

Authors:  Katelin D Cherry; Richard A Schwarz; Eric C Yang; Imran S Vohra; Hawraa Badaoui; Michelle D Williams; Nadarajah Vigneswaran; Ann M Gillenwater; Rebecca Richards-Kortum
Journal:  Cancer Prev Res (Phila)       Date:  2019-08-26

2.  Loss of heterozygosity as a marker to predict progression of oral epithelial dysplasia to oral squamous cell carcinoma.

Authors:  Umadevi Krishna Mohan Rao; Rooban Thavarajah; Elizabeth Joshua; Kannan Ranganathan
Journal:  J Oral Maxillofac Pathol       Date:  2018 May-Aug

3.  UK consensus recommendations on the management of oral epithelial dysplasia during COVID-19 pandemic outbreaks.

Authors:  Caroline Elizabeth McCarthy; Stefano Fedele; Michael Ho; Richard Shaw
Journal:  Oral Oncol       Date:  2020-11-19       Impact factor: 5.337

Review 4.  New Insights into Oral Cancer-Risk Factors and Prevention: A Review of Literature.

Authors:  Soussan Irani
Journal:  Int J Prev Med       Date:  2020-12-30

5.  Molecular drivers of oral cavity squamous cell carcinoma in non-smoking and non-drinking patients: what do we know so far?

Authors:  Sophia Uddin; Alka Singh; Vasudha Mishra; Nishant Agrawal; Zhen Gooi; Evgeny Izumchenko
Journal:  Oncol Rev       Date:  2022-02-22

6.  Malignant transformation of oral leukoplakia: a multicentric retrospective study in Brazilian population.

Authors:  J-M Cerqueira; F-S Pontes; A-R Santos-Silva; O-P Almeida; R-F Costa; F-P Fonseca; R-S Gomez; N-C Neto; L-A Miyahara; C-I Rodrigues-Fernandes; E-D Neto; A-L Araújo
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2021-05-01

7.  Atypical extragingival occurrence of lobular capillary hemangioma: A report of two cases.

Authors:  Sneha R Sharma; Archana Mehra; Freny R Karjodkar; Kaustubh P Sansare
Journal:  J Indian Soc Periodontol       Date:  2021-05-03

Review 8.  Difficulties in the Prognostic Study of Oral Leukoplakia: Standardisation Proposal of Follow-Up Parameters.

Authors:  Cristina Saldivia-Siracusa; Wilfredo Alejandro González-Arriagada
Journal:  Front Oral Health       Date:  2021-02-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.